Transaction · 0001193125-26-380023

LEE WILLIS C

LEE WILLIS C, CEO, reported an open-market or private purchase at Emmaus Life Sciences, Inc. involving 170000.000000 shares for an estimated $1700.00. Reported holdings after the transaction were 275400.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

Open-market buySEC transaction code PCEO
EMMAEmmaus Life Sciences, Inc.
Filing timeSep 02
Trade dateAug 29, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
—
Pre-filing
1mo ago1w ago1d ago
Returns since
7d30d90d180d1y

EMMA price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
EMMA since 2026-09-02Filed yesterday · 1 day of post-filing data
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Buy
Code P
Identifier
0001193125-26-380023
Common stock, $0.001 par value
Transaction date
Aug 29, 2025
Filed Sep 02, 2026, 07:05 PM · 369d delay
Shares
170k sh
$1 per share
Estimated value
$170k
Computed from shares × price
Holdings after
275k sh
Indirect · Fidelity Roth IRA FBO Willis C. Lee

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 369 calendar days after the transaction date.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
CEO Buy Delayed Filing Director Buy Large Holdings Increase
+26score
Filing-only score

+26

Compact filing score computed from stored Form 4 facts. Version v1.

Strong filing signal

This filing has a high positive filing-only score. It may deserve closer research, but it is not an investment recommendation.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

CEO

Officer YesDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.01 to $0.02, inclusive. The reporting person undertakes to provide to Emm…

  2. F2

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.0109 to $0.011, inclusive.

  3. F3

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.034 to $0.039, inclusive.

  4. F4

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.044 to $0.051, inclusive.

  5. F5

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.050 to $0.075, inclusive.

  6. F6

    The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.046 to $0.05, inclusive.

Original filing · 0001193125-26-380023
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

EMMA